Key result
Three-dimensional global longitudinal strain was independently associated with extensive late gadolinium enhancement in hypertrophic cardiomyopathy.
Why the study?
While 2D-STE for detecting fibrosis is validated against CMR-LGE in HCM, whether 3D-STE can quantify replacement fibrosis as a surrogate for CMR-LGE is unknown.
Can 3-dimensional speckle-tracking echocardiography (3D-STE) accurately quantify replacement fibrosis as a surrogate for CMR-LGE in patients with hypertrophic cardiomyopathy?
Observational (n=511)
Can 3-dimensional speckle-tracking echocardiography (3D-STE) accurately quantify replacement fibrosis as a surrogate for CMR-LGE in patients with hypertrophic cardiomyopathy?
3D-STE global longitudinal strain correlates strongly with CMR-LGE and can accurately detect extensive replacement fibrosis in patients with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support 3D GLS for fibrosis assessment in HCM; hypothesis-generating and requires validation before changing practice.
BACKGROUND Two-dimensional (2D) speckle-tracking echocardiography (STE) for fibrosis detection has been validated against cardiac magnetic resonance late gadolinium enhancement (CMR-LGE) in hypertrophic cardiomyopathy (HCM), whereas 3-dimensional speckle-tracking echocardiography (3D-STE) may overcome limitations of 2D imaging. OBJECTIVES The authors aimed to evaluate whether 3D-STE can quantify replacement fibrosis as a surrogate for CMR-LGE. METHODS Two-dimensional speckle-tracking echocardiography, 3D-STE, and the extent of late gadolinium enhancement (%LGE) were prospectively measured in patients with HCM within ≤72 hours. RESULTS Among 511 patients with HCM (age 49.0 ± 14.3 years; men 340/511, 66.5%), strain parameters were significantly lower in patients with HCM and LGE [LGE (+)] than those in patients without LGE [LGE (-)]. Three-dimensional global longitudinal strain (GLS-3D) correlated moderately with GLS-2D (r = 0.622; 95% CI: 0.565-0.672; P < 0.001) and most strongly with %LGE (r = -0.698; 95% CI: -0.741 to -0.649; P < 0.001). A quadratic model explained the relationship between GLS-3D and %LGE better than the linear model (R2 = 0.448 vs 0.381). GLS-3D was independently associated with extensive LGE (%LGE ≥15%) (OR = 0.629; 95% CI: 0.553-0.716; P < 0.001), and showed the highest AUC for detecting extensive LGE (AUC = 0.894; 95% CI: 0.854-0.934; P < 0.001). At a cutoff value of 15.25%, GLS-3D yielded 87.3% sensitivity (95% CI: 75.5%-94.7%) and 78.3% specificity (95% CI: 74.4-82.2%). CONCLUSIONS GLS-3D showed the strongest correlation with %LGE among strain parameters and may serve as a surrogate marker for CMR-LGE in HCM.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted an observational in Hypertrophic cardiomyopathy (n=511). Three-dimensional speckle-tracking echocardiography (3D-STE) vs. Two-dimensional speckle-tracking echocardiography (2D-STE) was evaluated on Extensive late gadolinium enhancement (%LGE ≥15%) (OR 0.629, 95% CI 0.553-0.716, p=<0.001). Three-dimensional global longitudinal strain was independently associated with extensive late gadolinium enhancement in hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: